Pelvic shoulder dysplasia
Pelvic Shoulder Dysplasia is a rare congenital disorder characterized by abnormalities in the development of the pelvis and shoulder girdle. The condition is part of a group of disorders known as skeletal dysplasias, which affect the growth and development of bones and cartilage. Pelvic Shoulder Dysplasia is notable for its impact on the shoulder blades (scapulae) and the pelvis, leading to a range of physical challenges and potential mobility issues for those affected.
Symptoms and Diagnosis[edit]
The primary symptoms of Pelvic Shoulder Dysplasia include underdeveloped or malformed pelvic bones and shoulder blades. This can lead to a noticeable difference in shoulder height, limited range of motion in the shoulders and hips, and potential difficulties with walking or movement. Diagnosis is typically made through a combination of physical examination and imaging studies, such as X-rays, which can reveal the characteristic abnormalities in bone structure.
Causes[edit]
The exact cause of Pelvic Shoulder Dysplasia remains unknown, but it is believed to involve genetic factors. It may occur as a spontaneous mutation or be inherited in an autosomal recessive manner, meaning that a child must inherit one copy of the mutated gene from each parent to be affected.
Treatment[edit]
Treatment for Pelvic Shoulder Dysplasia focuses on managing symptoms and improving mobility. This may include physical therapy to strengthen muscles and improve range of motion, as well as surgical interventions to correct bone abnormalities. Orthopedic specialists play a key role in the treatment and management of this condition.
Prognosis[edit]
The prognosis for individuals with Pelvic Shoulder Dysplasia varies depending on the severity of the condition and the effectiveness of treatment. With early intervention and appropriate care, many individuals can lead active and fulfilling lives.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
